NeueHealth Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Revenue	1,161	751.16	1,513	1,207	280.67	130.63
Revenue Growth (YoY)	54.53%	-50.35%	25.32%	330.15%	114.86%	-
Cost of Revenue	996.58	662.97	1,294	1,047	224.39	96.41
Gross Profit	164.22	88.19	218.88	160.02	56.29	34.23
Selling, General & Admin	287.14	354.44	527.45	409.33	180.49	95.84
Other Operating Expenses	454.08	102.51	35.05	8.29	1.13	1.03
Operating Expenses	741.22	456.95	562.5	417.62	181.62	96.87
Operating Income	-577	-368.76	-343.63	-257.6	-125.34	-62.64
Interest Expense / Income	38.2	12.82	7.23	0	0	0
Other Expense / Income	537.68	1,070	860.53	-	-	-
Pretax Income	-1,152.88	-1,451.88	-1,211.38	-257.6	-125.34	-62.64
Income Tax	-1.43	3.66	-26.52	-9.16	0	0
Net Income	-1,151.45	-1,455.54	-1,184.86	-248.44	-125.34	-62.64
Preferred Dividends	49.15	39.69	0	0	0	0
Net Income Common	-1,200.6	-1,495.23	-1,184.86	-248.44	-125.34	-62.64
Shares Outstanding (Basic)	8	8	5	2	2	2
Shares Outstanding (Diluted)	8	8	5	2	2	2
Shares Change	1.09%	60.47%	188.01%	1.27%	1.90%	-
EPS (Basic)	-150.94	-190.04	-241.60	-145.60	-74.40	-37.60
EPS (Diluted)	-150.94	-190.04	-241.60	-145.60	-74.40	-37.60
Free Cash Flow	-2,729.44	207.02	51.65	-63.71	-9	-27.73
Free Cash Flow Per Share	-343.15	26.31	10.53	-37.42	-5.35	-16.81
Gross Margin	14.15%	11.74%	14.47%	13.25%	20.05%	26.20%
Operating Margin	-49.71%	-49.09%	-22.71%	-21.34%	-44.66%	-47.95%
Profit Margin	-103.43%	-199.06%	-78.31%	-20.58%	-44.66%	-47.95%
Free Cash Flow Margin	-235.13%	27.56%	3.41%	-5.28%	-3.21%	-21.23%
EBITDA	-1,090.51	-1,388.48	-1,168.67	-249.31	-124.2	-61.61
EBITDA Margin	-93.94%	-184.84%	-77.24%	-20.65%	-44.25%	-47.16%
Depreciation & Amortization	24.17	50.58	35.48	8.29	1.13	1.03
EBIT	-1,114.68	-1,439.06	-1,204.15	-257.6	-125.34	-62.64
EBIT Margin	-96.03%	-191.58%	-79.59%	-21.34%	-44.66%	-47.95%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).